Two-year outcomes after transcatheter aortic valve-in-valve implantation in degenerated surgical valves.

Abdelrahman Ibrahim Abushouk Omar M Abdelfattah Mohamed M GadAnas SaadEssa HaririToshiaki IsogaiShashank ShekharGrant W ReedRishi PuriJames YunPatrick R VargoAaron J WeissDaniel BurnsShinya UnaiZoran PopovicSerge C HarbAmar KrishnaswamyLars G SvenssonDouglas R JohnstonSamir R Kapadia

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)

ViV-TAVI for degenerated surgical valves was associated with favorable 2-year clinical and hemodynamic outcomes. Further studies are needed to better understand the role of ViV-TAVI as a treatment option in the life management of aortic valve disease.

Keyphrases

aortic valve
transcatheter aortic valve implantation
transcatheter aortic valve replacement
aortic valve replacement
aortic stenosis
metabolic syndrome
insulin resistance
coronary artery disease
atrial fibrillation
mitral valve
skeletal muscle
weight loss
replacement therapy